MicroRNA‐411‐3p inhibits bleomycin‐induced skin fibrosis by regulating transforming growth factor‐β/Smad ubiquitin regulatory factor‐2 signalling
Open Access
- 15 November 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (24) , 11290-11299
Abstract
Skin fibrosis, which is characterized by fibroblast proliferation and increased extracellular matrix, has no effective treatment. An increasing number of studies have shown that microRNAs (miRNAs/miRs) participate in the mechanism of skin fibrosis, such as in limited cutaneous systemic sclerosis and pathological scarring. The objective of the present study was to determine the role of miR‐411‐3p in bleomycin (BLM)‐induced skin fibrosis and skin fibroblast transformation. Using Western blot analysis and real‐time quantitative polymerase chain reaction assess the expression levels of miR‐411‐3p, collagen (COLI) and transforming growth factor (TGF)‐β/Smad ubiquitin regulatory factor (Smurf)‐2/Smad signalling factors both in vitro and in vivo with or without BLM. To explore the regulatory relationship between miR‐411‐3p and Smurf2, we used the luciferase reporter assay. Furthermore, miR‐411‐3p overexpression was identified in vitro and in vivo via transfection with Lipofectamine 2000 reagent and injection. Finally, we tested the dermal layer of the skin using haematoxylin and eosin and Van Gieson's staining. We found that miR‐411‐3p expression was decreased in bleomycin (BLM)‐induced skin fibrosis and fibroblasts. However, BLM accelerated transforming growth factor (TGF)‐β signalling and collagen production. Overexpression of miR‐411‐3p inhibited the expression of collagen, F‐actin and the TGF‐β/Smad signalling pathway factors in BLM‐induced skin fibrosis and fibroblasts. In addition, miR‐411‐3p inhibited the target Smad ubiquitin regulatory factor (Smurf)‐2. Furthermore, Smurf2 was silenced, which attenuated the expression of collagen via suppression of the TGF‐β/Smad signalling pathway. We demonstrated that miR‐411‐3p exerts antifibrotic effects by inhibiting the TGF‐β/Smad signalling pathway via targeting of Smurf2 in skin fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (81972988)
- Hebei Provincial Key Research Projects (192777129D)
This publication has 31 references indexed in Scilit:
- Non-Coding RNAs: The New Insight on Hypertrophic ScarJournal of Cellular Biochemistry, 2017
- RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signalingJournal of Biological Chemistry, 2017
- Non-Coding RNAs: New Players in Skin Wound HealingAdvances in Wound Care, 2017
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseasesNature Reviews Drug Discovery, 2017
- Les cicatrices chéloïdes (deuxième partie) : arsenal et stratégie thérapeutiqueAnnales de Chirurgie Plastique Esthétique, 2017
- miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancerInternational Journal of Oncology, 2015
- Inhibition of Smurf2 translation by miR-322/503 modulates TGF-β/Smad2 signaling and intestinal epithelial homeostasisMolecular Biology of the Cell, 2014
- Targeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosisThe FASEB Journal, 2013
- Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin LigasesJournal of Biological Chemistry, 2005
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999